The management of hyperkalaemia in the emergency department

Journal of Accident and Emergency Medicine

Volumn 17, Issue 3, 2000, Pages 188-191

  Ahee, Peter ^a   Crowe, Alexander V ^b  

^a CITY HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Hyperkalaemia

Indexed keywords

GLUCONATE CALCIUM; GLUCOSE; INSULIN; POLYSTYRENESULFONATE SODIUM; SALBUTAMOL; SODIUM CARBONATE;

ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY FAILURE; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; EMERGENCY TREATMENT; EMERGENCY WARD; HEMODIALYSIS; HUMAN; HYPERKALEMIA;

EID: 0034012131     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.17.3.188     Document Type: Article

References (29)

1. Mandal AK. Hypokalemia and hyperkalemia. Med Clin North Am 1997;81:611-39.
2. Allon M, Dunlay R, Copkney C. Nebulised albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989;110:426-9.
3. Kim HJ. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996;72:476-82.
4. Murdoch IA, Dos Anjos R, Haycock GB. Treatment of hyperkalemia with intravenous salbutamol. Arch Dis Child 1991;66:527-8.
5. Lens XM, Montoliu J, Cases A, et al. Treatment of hyperkalemia in renal failure: Salbutamol v insulin. Nephrol Dial Transplant 1989;4:228-32.
6. Liou HH, Chiang SS, Wu SC, et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis 1994;23:266-71.
7. Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 1996;28:508-14.
8. Noyan A, Anarat A, Pirti M, et al. Treatment of hyperkalemia in children with intravenous salbutamol. Acta Paediatr Jpn 1995;37:355-7.
9. Liou HH, Chiang SS, Wu SC, et al. Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua I Hsueh Tsa Chih Taipei 1994;53:276-81.
10. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990;38: 869-72.
11. Montoliu J, Lens XM, Revert L. Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Arch Intern Med 1987;147:713-17.
12. Blumberg A, Weidmann P, Shaw S, et al. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988;85:507-12.
13. Montoliu J, Almirall J, Ponz E, et al. Treatment of hyperkalemia in renal failure with salbutamol inhalation. J Intern Med 1990;228:35-7.
14. Kemper MJ, Harps E, Hellwege HH, et al. Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol. Eur J Pediatr 1996;155:495-7.
15. McClure RJ, Prasad VK, Brocklebank JT. Treatment of hyperkalaemia using intravenous and nebulised salbutamol. Arch Dis Child 1994;70:126-8.
16. Kim HJ. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients. J Korean Med Sci 1997;12:111-16.
17. Duranay M, Ates K, Erturk S, et al. Comparison of aminophylline and insulin infusions in treatment of hyperkalemia in patients with end-stage renal disease. Nephron 1996;73: 105.
18. Ljutic D, Rumboldt Z. Should glucose be administered before, with, or after insulin, in the management of hyperkalemia? Ren Fail 1993;15:73-6.
19. Allon M. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 1993;43:1197-209.
20. Salem MM, Rosa RM, Batlle DC. Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia. Am J Kidney Dis 1991;18:421-40.
21. Wrenn KD, Slovis CM, Slovis BS. The ability of the physician to predict hyperkalemia from the ECG. Ann Emerg Med 1991;20:1229-32.
22. Semmekrot BA, Monnens LA. A warning for the treatment of hyperkalaemia with salbutamol. Eur J Pediatr 1997;156: 420.
23. Du-Plooy WJ, Hay L, Kahler CP, et al. The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. Br J Pharmacol 1994;111:73-6.
24. Advanced Life Support Group. Paediatric life support: the practical approach. 2nd ed. London: BMJ Publishing Group, 1997:254.
25. Roy-Chaudhury P, Meisels IS, Freedman S, et al. Combined gastric and ileocecal toxicity (serpiginous ulcers) after oral kayexalate in sorbital therapy. Am J Kidney Dis 1997;30: 120-2.
26. Lin JL, Lim PS, Leu ML, et al. Outcomes of severe hyperkalemia in cardiopulmonary resuscitation with concomitant hemodialysis. Intensive Care Med 1994;20:287-90.
27. Blumberg A, Weidman P, Shaw S, et al. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988; 85:507-12.
28. Feig PU, Shook A, Sterns RH. Effect of potassium removal during haemodialysis on the plasma potassium concentration. Nephron 1981;27:25-30
29. Allon M, Shanklin N. Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis 1995; 26:607-13.